NavSTAR for Opioid Use Disorder
This study is looking at how to best use an intervention called NavSTAR to help people with opioid use disorder (OUD) get into treatment after they leave the hospital. NavSTAR involves working with a trained patient navigator who provides support and motivational content. The study aims to find solutions for widely implementing NavSTAR across a health system. You may be able to join if you are 18 or older, have moderate to severe OUD, and can give informed consent in English. The main goal is to see how many people start opioid agonist treatment (OAT) within three months. The study status is unclear, and it plans to enroll 720 participants.
- Study design
- This is an interventional study with a planned enrollment of 720 participants. It is a type II hybrid implementation-effectiveness trial of NavSTAR.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary outcome, opioid agonist treatment initiation, is measured at 3 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
NavSTAR Implementation Effectiveness Trial Across a Health System
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Rate of Opioid Agonist Treatment initiation3 months
Post-discharge rate of OAT initiation will be ascertained via health record review and self-report with verification through records where applicable (e.g., Community Behavioral Health system).